Biovista

The company began operations in 1996 with the initial aim of supplying corporate intelligence products and services in the biotechnology sector.
Having initially developed and sold to customers world-wide analyses of areas such as combinatorial chemistry, target validation, bioinformatics, carbohydrate therapeutics and others, Biovista focused on combining its capabilities in AI and NLP.

Biovista has built a proprietary software platform called Discovery AlgorithmicsTM and is using this to create a suite of products that help solve knowledge-intensive bottlenecks.

To date, the company is financed through direct sales and EU funding for collaborative research.

Contact Details: 927 Raymond Road Charlottesville Virginia 22902 United States of America Tel: 1.434.2426514 Fax: 1.434.9846027 Email: info@biovista.com WWW: www.biovista.com/

Loading...

Recent Publications by Biovista:
Handling of computational in vitro/in vivo correlation problems by Microsoft Excel: V. Predictive absorbability models. This paper discusses Excel applications related to the prediction of drug...	12th September, 2007	BioVista LLC,	Eur J Pharm Biopharm. 2007 Aug;67(1):293-9. Epub 2007 Feb 8. DOI Direct Link
Handling of computational in vitro/in vivo correlation problems by Microsoft Excel: IV. Generalized matrix analysis of linear compartment systems. A linear system comprising n compartments is completely defined by the...	20th April, 2005	BioVista	Eur J Pharm Biopharm. 2005 Jan;59(1):229-35. DOI Direct Link
Handling of computational in vitro/in vivo correlation problems by Microsoft Excel: III. Convolution and deconvolution. Convolution and deconvolution are the classical in-vitro-in-vivo...	18th August, 2004	BioVista	Eur J Pharm Biopharm. 2003 Nov;56(3):429-37.
Handling of computational in vitro/in vivo correlation problems by Microsoft Excel II. Distribution functions and moments. MS Excel is a useful tool to handle in vitro/in vivo correlation (IVIVC)...	27th September, 2003	BioVista	Eur J Pharm Biopharm. 2003 Jan;55(1):77-84.

Press Releases on Biovista:
Biovista Inc. Announces Positive Efficacy Results in a Pre-Clinical Trial of its BVA-601 Repositioned Drug for Epilepsy	23rd June, 2009	Biovista Inc.	CHARLOTTESVILLE, Virginia, June 23 /PRNewswire/ -- Biovista Inc. today announced that BVA-601, its small-molecule drug targeting epilepsy, has shown positive results in the Kainic acid murine
Biovista Inc. Announces Positive Efficacy Results in a Pre-Clinical Trial of its BVA-101 Repositioned Drug for Multiple Sclerosis	2nd April, 2009	Biovista Inc.	CHARLOTTESVILLE, Virginia, April 2 /PRNewswire/ -- Biovista Inc. today announced that BVA-101, its drug targeting Multiple Sclerosis (MS), has shown significant positive results in the MOG-induced

BioNews Results for Biovista:
Biovista Reports Positive Efficacy Results In Pre-clinical Trial For BVA-201	Pharmaceutical Business Review:  Sep 11 2009 10:52AM Matching: biovista

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 363 times since April 2007, the link to the organisation's website has been followed 49 times

Search for more companies in Charlottesville

Search for more companies in Virginia

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Biovista